Toshifumi Mikayama

Director/Board Member at KYOWA KIRIN CO. LTD.

66 year

Health Technology

Profile

Toshifumi Mikayama has held positions as a Director at Kyowa Kirin International Plc since 2012 and as a Director & Vice President at Kyowa Kirin Co., Ltd.
since 2008.

Toshifumi Mikayama active positions

Companies	Position	Start
KYOWA KIRIN CO. LTD.	Director/Board Member	2014-02-28
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Director/Board Member	2012-03-06

All active positions of Toshifumi Mikayama

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Toshifumi Mikayama's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
KYOWA KIRIN CO. LTD.	Health Technology

Private companies	1
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Health Technology